Stocks turn negative despite more positive vaccine trial data: Nov 18
Stocks fell Wednesday afternoon, reversing earlier gains after new data from Pfizer (PFE) helped momentarily stoke investor confidence that an effective vaccine will become available in the coming months. The pharmaceutical company reported Wednesday that it had concluded its Phase 3 trial of its vaccine candidate, and found its inoculation to be 95% effective against COVID-19.
